Journal
EXPERT REVIEW OF ANTICANCER THERAPY
Volume 9, Issue 4, Pages 437-452Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERA.09.10
Keywords
nonviral delivery; nuclear translocation; small-cell lung cancer; suicide genes; transcriptionally targeted gene therapy; tumor-suppressor genes
Categories
Ask authors/readers for more resources
Small-cell lung cancer (SCLC) is a highly malignant disease with poor prognosis. Hence, there is great demand for new therapies that can replace or supplement the current available treatment regimes. Gene therapy constitutes a promising strategy and relies on the principle of introducing exogenous DNA into malignant cells causing them to die. Since SCLC is a highly disseminated malignancy, the gene therapeutic agent must be administered systemically, obligating a high level of targeting of tumor tissue and the use of delivery vehicles designed for systemic circulation of the therapeutic DNA. This review describes and discusses the current status of the application of gene therapy in relation to SCLC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available